Proteomics International Laboratories (ASX:PIQ) Cash Payments: A$-11.46 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:PIQ Proteomics International Laboratories Ltd ASX:PIQ
31 GF Score
Price A$0.20
GF Value A$0.48
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Proteomics International Laboratories Cash Payments?

Proteomics International Laboratories ASX:PIQ +5.41% 31 Cash Payments is A$-11.46 Mil as of Dec. 2025. GuruFocus rates ASX:PIQ with a GF Score™ of 31/100 and a GF Value™ of A$0.48 (Possible Value Trap). The stock has 3 warning signs investors should review.

Proteomics International Laboratories's Cash Payments for the six months ended in Dec. 2025 was A$-5.73 Mil.

Proteomics International Laboratories's Cash Payments for the trailing twelve months (TTM) ended in Dec. 2025 was A$-11.46 Mil.

Proteomics International Laboratories Cash Payments Historical Data

* Premium members only.

The historical data trend for Proteomics International Laboratories's Cash Payments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteomics International Laboratories Cash Payments Chart

Proteomics International Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Payments
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.73 -6.48 -9.56 -8.51 -9.98

Proteomics International Laboratories Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Payments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.80 -4.71 -4.25 -5.73 -5.73
ASX:PIQ
31GF Score
Proteomics International Laboratories Ltd ASX:PIQ
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Proteomics International Laboratories Cash Payments Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Payments represents cash flow paid from operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Payments" section for non-financial companies:
Payments to Suppliers for Goods and Services
Payments on Behalf of Employees
Other Cash Payments from Operating Activities

Cash Payments for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-11.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Payments →
What does a Cash Payments of A$-11.46 Mil mean?
Proteomics International Laboratories (ASX:PIQ) has a Cash Payments of A$-11.46 Mil as of Dec. 2025. Cash Payments represents cash paid from operating activities in direct cash flow method. View historical data for Proteomics International Laboratories and its competitors.
Is Proteomics International Laboratories' Cash Payments too high?
Proteomics International Laboratories' current Cash Payments is A$-11.46 Mil. Overall, Proteomics International Laboratories has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Proteomics International Laboratories' Cash Payments compare to VRTX and REGN?
Proteomics International Laboratories' Cash Payments of A$-11.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Payments for a Biotechnology company?
A good Cash Payments depends on the Biotechnology industry context. However, Cash Payments should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Payments mean?
A high Cash Payments can signal that a stock is expensive relative to its fundamentals. Cash Payments represents cash paid from operating activities in direct cash flow method. View historical data for Proteomics International Laboratories and its competitors. Proteomics International Laboratories's current Cash Payments is A$-11.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteomics International Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Proteomics International Laboratories (ASX:PIQ) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.48, compared to a current price of A$0.20 — trading 59.4% below its estimated fair value. The current Cash Payments is A$-11.46 Mil. Proteomics International Laboratories' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Payments calculated?
Cash Payments is calculated from a company's financial statements. For Proteomics International Laboratories (ASX:PIQ), the current Cash Payments is A$-11.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Proteomics International Laboratories (ASX:PIQ) Overvalued in 2026?

Based on GuruFocus' analysis, Proteomics International Laboratories stock appears to be undervalued. The current stock price of A$0.20 is trading 59.4% below its estimated GF Value™ of A$0.48. GuruFocus considers Proteomics International Laboratories to be Possible Value Trap.

Key valuation signals for ASX:PIQ:

  • Cash Payments: A$-11.46 Mil
  • GF Value™: A$0.48 vs. price of A$0.20 (59.4% below fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the ASX:PIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Proteomics International Laboratories Business Description

Address 6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. It is a pioneering medical technology company operating at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics-the industrial-scale study of the structure and function of proteins. Its pipeline includes Promarker, Pipeline PromarkerD, PromarkerEndo, PromarkerEso, and OxiDx.
31GF Score

Get the complete analysis for ASX:PIQ

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.20
Price
A$0.48
GF Value